Goldman Sachs’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-62,608
Closed -$1.37M 6610
2017
Q3
$1.37M Buy
+62,608
New +$1.41M ﹤0.01% 4310

Other funds holding SBRA

Goldman Sachs's SBRA Position: Q1 2026 in Review

Goldman Sachs increased its Sabra Healthcare REIT (SBRA) stake by 51% in Q1 2026, buying an estimated $24.7M and bringing the position to 3,733,941 shares worth $71.8M. The position accounts for 0.01% of the portfolio, ranked #1280.

Goldman Sachs first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.7M in Q1 2022. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Goldman Sachs held 3,733,941 shares of Sabra Healthcare REIT worth $71.8M as of Q1 2026.
  • Goldman Sachs bought 1,253,365 Sabra Healthcare REIT shares in Q1 2026, an estimated $24.7M.
  • Sabra Healthcare REIT made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1280 holding.
  • Goldman Sachs first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Sabra Healthcare REIT position peaked at $81.7M in Q1 2022.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.